Kent Snyder

Biography

Kent Snyder joined the BioAtla Board in December, 2016. Currently, Mr. Snyder serves as Chairman of the Board of Senomyx, Inc., a biotechnology company focused on the science of taste. Previously, Mr. Snyder also served as the CEO of Senomyx from 2003-2014. Prior to his tenure at Senomyx, from July 1991 to October 2001, Mr. Snyder held various commercial positions with Agouron Pharmaceuticals, Inc., a Pfizer company. Mr. Snyder’s most recent position was President of Global Commercial Operations, and prior to that Mr. Snyder served as Senior Vice President of Commercial Affairs and Vice President of Business Development. Mr. Snyder is a former Director of Santarus, Inc., a biopharmaceutical company and a former Director of VentiRx Pharmaceuticals, a company focused on the field of oncology. Mr. Snyder received his B.S. from the University of Kansas and his M.B.A. from Rockhurst College.

Research Interest

oncology